Mukka Proteins Ltd

Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Sell to Hold as of 16 June 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, and recent financial trends. Despite lingering concerns over long-term fundamentals, the stock’s recent performance and market positioning have prompted a reassessment by analysts.

Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by improvements in key indicators such as the MACD and Bollinger Bands on the weekly chart, alongside a recent upgrade in its MarketsMOJO grade from Sell to Hold, signalling cautious optimism among investors.

Mukka Proteins Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong day gain of 6.24%, the micro-cap FMCG stock remains under pressure with a Mojo Grade of Sell, signalling cautious investor sentiment amid mixed market cues.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd is rated Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Mukka Proteins Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's present condition as of 17 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Mukka Proteins Ltd., a micro-cap player in India's FMCG sector, reported a consolidated net profit of ₹20.62 crores for Q4 FY26, marking a robust 51.73% year-on-year growth despite a sequential decline of 13.18% from the previous quarter. The ₹729 crore market capitalisation company's shares have struggled post-results, trading at ₹23.60 as of May 15, down 1.46% and languishing 28.03% below their 52-week high of ₹32.79.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 1.39% to close at ₹22.60, the stock’s technical indicators present a complex picture, reflecting cautious optimism tempered by persistent downward pressures.

Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

For the third consecutive session, Mukka Proteins Ltd has closed lower, hitting a fresh all-time low of Rs 18.44 on 30 Mar 2026. This decline comes amid broader sector weakness but notably outpaces the Aquaculture sector's fall, signalling stock-specific pressures.

For the third consecutive session, Mukka Proteins Ltd has closed lower, culminating in a fresh 52-week low of Rs 18.74 on 30 Mar 2026. This decline extends the stock’s year-long slide to over 42%, markedly underperforming the broader Sensex, which has fallen just 6.23% over the same period.